www.nasdaq.com/de/symbol/cprx/real-time
|
Aktie fällt trotz FDA Approval
www.fool.com/investing/2018/11/29/...ock-is-sinking-toda.aspx
Adam Feuerstein meint dazu auf Twitter:
"$375K per year for Firdapse — an old, cheap drug already in use that $CPRX did nothing to improve, just jumped through a regulatory loophole. Deplorable."
www.statnews.com/2018/11/30/fda-approval-lems-drug-costs/
Catalyst nutzt "Lücke im System" aus
blogs.sciencemag.org/pipeline/archives/...fda-for-this-fiasco
|
Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
2 | 208 | CATALYST PHARM PARTNERS INC are yo ready ? | Reggio Emilia | Biotecfan | 06.03.24 23:10 |